Literature DB >> 14714431

Japanese encephalitis.

Scott B Halstead1, Julie Jacobson.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14714431     DOI： 10.1016/s0065-3527(03)61003-1

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN： 0065-3527            Impact factor:   9.937


× No keyword cloud information.
  39 in total

Review 1.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

2.  A novel low-cost approach to estimate the incidence of Japanese encephalitis in the catchment area of three hospitals in Bangladesh.

Authors:  Repon C Paul; Mahmudur Rahman; Emily S Gurley; M Jahangir Hossain; Serguei Diorditsa; Asm Mainul Hasan; Sultana S Banu; Asm Alamgir; Muhammad Aziz Rahman; Hardeep Sandhu; Marc Fischer; Stephen P Luby
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

3.  Japanese encephalitis in travelers from non-endemic countries, 1973-2008.

Authors:  Susan L Hills; Anne C Griggs; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

4.  Japanese encephalitis virus utilizes the canonical pathway to activate NF-kappaB but it utilizes the type I interferon pathway to induce major histocompatibility complex class I expression in mouse embryonic fibroblasts.

Authors:  Sojan Abraham; Ashwini Sankrepatna Nagaraj; Soumen Basak; Ramanathapuram Manjunath
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

5.  Disability after encephalitis: development and validation of a new outcome score.

Authors:  Penny Lewthwaite; Ashia Begum; Mong How Ooi; Brian Faragher; Boon Foo Lai; Indunil Sandaradura; Anand Mohan; Gaurav Mandhan; Pratibha Meharwade; S Subhashini; Gulia Abhishek; Asma Begum; Srihari Penkulinti; M Veera Shankar; R Ravikumar; Carolyn Young; Mary Jane Cardosa; V Ravi; See Chang Wong; Rachel Kneen; Tom Solomon
Journal:  Bull World Health Organ       Date:  2010-04-19       Impact factor: 9.408

6.  Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice.

Authors:  Kaushik Bharati; Y P S Malik; Sudhanshu Vrati
Journal:  Med Microbiol Immunol       Date:  2007-03-22       Impact factor: 3.402

7.  JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.

Authors:  Maximilian Larena; Natalie A Prow; Roy A Hall; Nikolai Petrovsky; Mario Lobigs
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

8.  Development of a vaccine to prevent Japanese encephalitis: a brief review.

Authors:  Viroj Wiwanitkit
Journal:  Int J Gen Med       Date:  2009-12-29

9.  Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests.

Authors:  Barbara W Johnson; Olga Kosoy; Elizabeth Hunsperger; Manuela Beltran; Mark Delorey; Farshad Guirakhoo; Thomas Monath
Journal:  Clin Vaccine Immunol       Date:  2009-05-20

10.  Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance.

Authors:  Susan Hills; Alya Dabbagh; Julie Jacobson; Anthony Marfin; David Featherstone; Joachim Hombach; Pem Namgyal; Manju Rani; Tom Solomon
Journal:  BMC Infect Dis       Date:  2009-12-29       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.